Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin vs Aspirin in HIV+ Elite Controllers and ART-Treated Patients
NCT02081638Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2014
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of atorvastatin and aspirin in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2014; status: completed.
02
Drugs
atorvastatinaspirin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02081638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02081638.